At Tolero, we’re developing novel therapeutics to treat cancer and other serious human diseases.

Targeted therapy is at the heart of
our pipeline.

Pipeline >

See why we’re investigating MCL-1
as a potential apoptosis inhibitor.

MCL-1 >

Learn about our clinical trials
currently underway.

Clinical Trials >